New injection shows promise for controlling severe eczema flares
Disease control
Completed
This study tested whether an intravenous medication called EVO301 could help control moderate to severe eczema in adults. 71 participants with significant eczema covering at least 10% of their body received either the drug or a placebo. Researchers measured changes in skin severi…
Phase: PHASE2 • Sponsor: Evommune, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC